These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17017293)

  • 1. [Duchenne muscular dystrophy: rational basis, state of the art].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):441-7. PubMed ID: 17017293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.
    Palmieri B; Tremblay JP; Daniele L
    Pediatr Transplant; 2010 Nov; 14(7):813-9. PubMed ID: 20963914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
    Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
    Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
    Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
    NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of duchenne muscular dystrophy: current hypotheses.
    Deconinck N; Dan B
    Pediatr Neurol; 2007 Jan; 36(1):1-7. PubMed ID: 17162189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic techniques described in the study of Duchenne/Becker muscular dystrophy].
    Montejo-Pujadas Y; Zaldívar-Vaillant T; Acevedo-López AM
    Rev Neurol; 2002 Feb 1-15; 34(3):278-81. PubMed ID: 12022080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular studies in Duchenne muscular dystrophy.
    Emery AE
    Prog Clin Biol Res; 1989; 306():15-28. PubMed ID: 2662210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
    Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene.
    Davies KE; Vogt J
    Neuromuscul Disord; 2024 Jun; 39():5-9. PubMed ID: 38653179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.
    Borrelli O; Salvia G; Mancini V; Santoro L; Tagliente F; Romeo EF; Cucchiara S
    Am J Gastroenterol; 2005 Mar; 100(3):695-702. PubMed ID: 15743370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
    Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
    Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
    Townsend D; Yasuda S; Metzger J
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers.
    Mosqueira M; Zeiger U; Förderer M; Brinkmeier H; Fink RH
    Med Res Rev; 2013 Sep; 33(5):1174-213. PubMed ID: 23633235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
    American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
    Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive heart failure with rhabdomyolysis and acute renal failure in a manifesting female carrier of Duchenne muscular dystrophy with duplication of dystrophin gene.
    Tunteeratum A; Witoonpanich R; Phudhichareonrat S; Eu-ahsunthornwattana J; Pingsuthiwong S; Srichan K; Sura T
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):49-53. PubMed ID: 19730022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role of dystrophin in neuronal excitability: a review of the current literature.
    Hendriksen RG; Hoogland G; Schipper S; Hendriksen JG; Vles JS; Aalbers MW
    Neurosci Biobehav Rev; 2015 Apr; 51():255-62. PubMed ID: 25677308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.